Scott Fidel
Stock Analyst at Stephens & Co.
(3.75)
# 733
Out of 5,055 analysts
184
Total ratings
68.75%
Success rate
5.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Overweight | $21 → $17 | $9.01 | +88.68% | 7 | Nov 14, 2025 | |
| CI The Cigna Group | Maintains: Buy | $370 → $330 | $269.66 | +22.38% | 14 | Nov 4, 2025 | |
| CNC Centene | Maintains: Sell | $33 → $38 | $36.38 | +4.45% | 11 | Oct 31, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $470 → $520 | $472.65 | +10.02% | 11 | Oct 27, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $207 → $167 | $137.54 | +21.42% | 11 | Oct 24, 2025 | |
| UHS Universal Health Services | Assumes: Neutral | $219 | $225.04 | -2.68% | 11 | Oct 14, 2025 | |
| THC Tenet Healthcare | Assumes: Buy | $224 | $192.91 | +16.12% | 11 | Oct 14, 2025 | |
| OSCR Oscar Health | Initiates: Neutral | $17 | $13.88 | +22.48% | 1 | Oct 14, 2025 | |
| ELV Elevance Health | Initiates: Neutral | $343 | $325.83 | +5.27% | 4 | Oct 14, 2025 | |
| ALHC Alignment Healthcare | Initiates: Buy | $21 | $16.52 | +27.12% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $91 | $77.81 | +16.95% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $406 | $321.86 | +26.14% | 23 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $142 | $108.90 | +30.39% | 12 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $38 | $24.93 | +52.43% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $48 → $31 | $10.58 | +193.01% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $177.89 | -6.12% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $29.21 | -28.11% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $237.12 | +5.43% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $113.46 | -7.46% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $16.03 | +473.92% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $8.45 | -82.25% | 3 | Nov 11, 2022 |
Ardent Health
Nov 14, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $9.01
Upside: +88.68%
The Cigna Group
Nov 4, 2025
Maintains: Buy
Price Target: $370 → $330
Current: $269.66
Upside: +22.38%
Centene
Oct 31, 2025
Maintains: Sell
Price Target: $33 → $38
Current: $36.38
Upside: +4.45%
HCA Healthcare
Oct 27, 2025
Maintains: Buy
Price Target: $470 → $520
Current: $472.65
Upside: +10.02%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $207 → $167
Current: $137.54
Upside: +21.42%
Universal Health Services
Oct 14, 2025
Assumes: Neutral
Price Target: $219
Current: $225.04
Upside: -2.68%
Tenet Healthcare
Oct 14, 2025
Assumes: Buy
Price Target: $224
Current: $192.91
Upside: +16.12%
Oscar Health
Oct 14, 2025
Initiates: Neutral
Price Target: $17
Current: $13.88
Upside: +22.48%
Elevance Health
Oct 14, 2025
Initiates: Neutral
Price Target: $343
Current: $325.83
Upside: +5.27%
Alignment Healthcare
Oct 14, 2025
Initiates: Buy
Price Target: $21
Current: $16.52
Upside: +27.12%
Oct 14, 2025
Initiates: Buy
Price Target: $91
Current: $77.81
Upside: +16.95%
Oct 14, 2025
Initiates: Buy
Price Target: $406
Current: $321.86
Upside: +26.14%
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $108.90
Upside: +30.39%
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $24.93
Upside: +52.43%
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $10.58
Upside: +193.01%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $177.89
Upside: -6.12%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $29.21
Upside: -28.11%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $237.12
Upside: +5.43%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $113.46
Upside: -7.46%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $16.03
Upside: +473.92%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $8.45
Upside: -82.25%